BIOGEN for BIOGEN
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation, including provisions related to corporate taxes, Medicare, and prescription drug pricing Mental Health Workforce Expansion The Mental Health Professionals Workforce Shortage Loan Repayment Act HELP Copays Act Issues related to ALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| JOHN RAYMOND GIBSON | — |
| TYLER HANSON | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
| ALI LAKHANI | — |
Medicare/Medicaid MMM
Drug cost and pricing policy issues Issues regarding coverage, coding, and reimbursement issues Issues regarding Alzheimer's treatments Issues related to the 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
Pharmacy PHA
Drug cost and pricing policy S.127, Pharmacy Benefit Manager Transparency Act and other PBM reforms Discussions regarding pharmaceutical issues related to supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON NICHOLAS BADIDA | — |
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) Research and Development Tax Credit American Innovation and Jobs Act Tax Provisions of Budget Reconciliation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
Trade (domestic/foreign) TRD
Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Budget/Appropriations BUD
Appropriations on mental health screening and diagnosis
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Copyright/Patent/Trademark CPT
Support stronger IP and exclusivity protections and enforcement in foreign markets
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.